Obvious Ventures

Obvious Ventures Research Investment Thesis Obvious Ventures is a leading purpose-driven venture capital firm founded on the belief that the most valuable companies of our time will be the ones solving humanity's biggest problems. The firm invests across three core pillars: planetary health, human health, and economic health. Rather than chasing trends, Obvious backs exceptional founders building breakthrough solutions that create both financial returns and positive impact on the world. The firm's investment philosophy centers on finding founders with audacious visions who are willing to tackle the world's most pressing challenges—from reversing chronic disease through personalized medicine to decarbonizing energy and transportation to improving financial access for underserved populations. Stage and Check Size Focus Obvious Ventures primarily targets Seed and Series A investments, with recent fund (Fund V, closed January 2026) planning approximately 10 investments per year. Their check size range has remained consistent: Check Size Range : $5 million to $12 million for seed and Series A rounds Historical Range : Previously $250K-$6M across earlier funds Target Ownership : Typically seeking 15-20% ownership at seed stage The firm maintains a disciplined deployment strategy, averaging around 10 investments annually rather than pursuing a high-volume approach. Recent Activity and Fund Status Obvious Ventures just closed Fund V in January 2026 at exactly $360,360,360—a mathematically meaningful number reflecting their "360-degree view" across the three core investment pillars. This represents the firm's continued fundraising success even during broader venture fundraising challenges. Fund Timeline: Fund I: $123,456,789 (2014) Fund II: $191,919,191 (2017) Fund III & IV: Combined $461 million (2022) Fund V: $360,360,360 (January 2026) Current AUM : Over $1 billion in assets under management Recent Investments (2025-2026): Zanskar (2026) - AI-driven geothermal energy discovery for clean baseload power Fleetzero (2026) - Electric vehicle fleet solutions Inductive Bio (2025) - AI-powered generative chemistry for sustainable materials Inceptive (2023) - mRNA therapeutic design using generative AI Ataraxis AI (2023) - AI precision medicine for cancer care The firm maintains active deployment despite market headwinds and is actively pursuing new investments in AI/ML infrastructure, climate tech, precision medicine, and workforce solutions. Portfolio Strength and Diversity Obvious has built one of the most impressive venture portfolios in the industry, with over 100+ portfolio companies spanning multiple successful exits and public companies: Public Companies: Recursion Pharmaceuticals (IPO) - AI-driven drug discovery, decoding biology at scale Planet Labs (IPO) - High-frequency satellite imaging for global insights Notable Success Stories: Gusto - Modern payroll and HR platform (Series D, $1B+ valuation) Beyond Meat - Plant-based protein leader (NASDAQ: BYND, IPO May 2019) Devoted Health - Medicare platform for senior care (major expansion) Diamond Foundry - Lab-grown diamonds with sustainable manufacturing Portfolio Depth Across Pillars: Human Health: Recursion, Virta Health, Devoted Health, Iterative Health, Brightside Health, Beam, MycoMedica, Dyno Therapeutics, Inceptive, Ataraxis AI, Gandeeva Therapeutics, Inductive Bio, and 20+ others Planetary Health: Planet, Pyka (electric autonomous aviation), Forum Mobility, Amply Energy, Zanskar, Synop (EV fleet management), Lightship (electric RVs), Canvas (construction robotics), and others Economic Health: Beyond Meat, Gusto, Incredible Health, Openly (insurance), Cal.com, Baton (SMB marketplace), Brightside Health, Prism Data, and others Team and Leadership Founders & Managing Directors: James Joaquin (Co-Founder & Managing Director) Vishal Vasishth (Co-Founder & Managing Director) Evan Williams (Co-Founder) - Twitter co-founder and serial entrepreneur Investment Leadership: Andrew Beebe (Managing Director) - Adds operational depth and company-building expertise Kahini Shah (Partner) - Healthcare and biotech focus Rohan Ganesh (Partner) - Technology and infrastructure investments Obvious Champions Network: The firm maintains an extensive advisory network including Glenn Kelman (Zillow CEO), Sachin Jain, Sue Siegel, Rodney Brooks (MIT Roboticist), Vivek Murthy (Former U.S. Surgeon General), and Amy Abernethy, MD. Investment Philosophy & Decision Process Decision Making: Partnership-based with strong conviction from managing directors Lead Tendency: Generally leads seed and Series A investments Involvement Style: Active board participation and operational support; strong focus on execution excellence Sector and Technology Focus Current portfolio demonstrates strength across: Healthcare & Biotech : AI-driven drug discovery, precision medicine, digital health Climate & Clean Energy : Geothermal, EV infrastructure, renewable energy Enterprise Software : Workforce solutions, financial technology Robotics & Automation : Warehouse automation, construction robotics Consumer Wellness : Plant-based alternatives, functional nutrition Founder Preferences Obvious explicitly seeks founders who: Have audacious visions for solving major problems Demonstrate both business acumen and deep domain expertise Share values-driven leadership philosophy Are willing to take calculated risks on moonshot ideas Show track records of persistence and learning Core Values The firm explicitly places great value on values and culture, holding portfolio companies to the highest ethical standards. B-Corp certified, the firm practices humility and audacity—taking bold risks while remaining grounded in mission-driven impact.